Vanguard Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,580,357
| Closed | -$8.24M | – | 4614 |
|
|
2023
Q2 | $8.24M | Sell |
8,580,357
-197,313
| -2% | -$195K | ﹤0.01% | 3058 |
|
|
2023
Q1 | $6.58M | Buy |
8,777,670
+377,383
| +4% | +$275K | ﹤0.01% | 3176 |
|
|
2022
Q4 | $3.1M | Sell |
8,400,287
-266,833
| -3% | -$113K | ﹤0.01% | 3507 |
|
|
2022
Q3 | $3.73M | Sell |
8,667,120
-161,556
| -2% | -$159K | ﹤0.01% | 3473 |
|
|
2022
Q2 | $6.89M | Buy |
8,828,676
+864,894
| +11% | +$762K | ﹤0.01% | 3196 |
|
|
2022
Q1 | $10.3M | Sell |
7,963,782
-1,528,539
| -16% | -$1.41M | ﹤0.01% | 3135 |
|
|
2021
Q4 | $12.1M | Sell |
9,492,321
-1,228,856
| -11% | -$2.2M | ﹤0.01% | 3118 |
|
|
2021
Q3 | $23.4M | Sell |
10,721,177
-2,623,108
| -20% | -$7.17M | ﹤0.01% | 2774 |
|
|
2021
Q2 | $50M | Buy |
13,344,285
+718,149
| +6% | +$2.5M | ﹤0.01% | 2371 |
|
|
2021
Q1 | $41.2M | Buy |
12,626,136
+527,765
| +4% | +$1.89M | ﹤0.01% | 2422 |
|
|
2020
Q4 | $41.3M | Buy |
12,098,371
+601,620
| +5% | +$2.48M | ﹤0.01% | 2305 |
|
|
2020
Q3 | $46.9M | Sell |
11,496,751
-624,563
| -5% | -$2.37M | ﹤0.01% | 2048 |
|
|
2020
Q2 | $41M | Sell |
12,121,314
-1,147,228
| -9% | -$3.34M | ﹤0.01% | 2101 |
|
|
2020
Q1 | $30.9M | Sell |
13,268,542
-287,549
| -2% | -$787K | ﹤0.01% | 2081 |
|
|
2019
Q4 | $49.3M | Buy |
13,556,091
+767,600
| +6% | +$6.2M | ﹤0.01% | 2110 |
|
|
2019
Q3 | $106M | Buy |
12,788,491
+815,850
| +7% | +$6.6M | ﹤0.01% | 1690 |
|
|
2019
Q2 | $103M | Buy |
11,972,641
+579,500
| +5% | +$5.18M | ﹤0.01% | 1737 |
|
|
2019
Q1 | $122M | Buy |
11,393,141
+281,134
| +3% | +$3.01M | ﹤0.01% | 1647 |
|
|
2018
Q4 | $97.2M | Buy |
11,112,007
+201,959
| +2% | +$2.57M | ﹤0.01% | 1696 |
|
|
2018
Q3 | $183M | Buy |
10,910,048
+639,075
| +6% | +$13.8M | 0.01% | 1449 |
|
|
2018
Q2 | $215M | Buy |
10,270,973
+1,703,989
| +20% | +$31.6M | 0.01% | 1292 |
|
|
2018
Q1 | $138M | Buy |
8,566,984
+634,790
| +8% | +$12.6M | 0.01% | 1528 |
|
|
2017
Q4 | $150M | Buy |
7,932,194
+932,780
| +13% | +$16.9M | 0.01% | 1478 |
|
|
2017
Q3 | $98.5M | Sell |
6,999,414
-293,290
| -4% | -$2.65M | ﹤0.01% | 1721 |
|
|
2017
Q2 | $54.3M | Buy |
7,292,704
+83,981
| +1% | +$549K | ﹤0.01% | 1979 |
|
|
2017
Q1 | $46.9M | Buy |
7,208,723
+874,871
| +14% | +$4.89M | ﹤0.01% | 2039 |
|
|
2016
Q4 | $28.1M | Buy |
6,333,852
+479,185
| +8% | +$2.01M | ﹤0.01% | 2257 |
|
|
2016
Q3 | $27.3M | Buy |
5,854,667
+230,475
| +4% | +$1.37M | ﹤0.01% | 2222 |
|
|
2016
Q2 | $37M | Buy |
5,624,192
+398,719
| +8% | +$2.82M | ﹤0.01% | 2031 |
|
|
2016
Q1 | $33.2M | Buy |
5,225,473
+101,441
| +2% | +$521K | ﹤0.01% | 2063 |
|
|
2015
Q4 | $30.9M | Buy |
5,124,032
+483,782
| +10% | +$2.77M | ﹤0.01% | 2117 |
|
|
2015
Q3 | $27.7M | Buy |
4,640,250
+318,182
| +7% | +$2.21M | ﹤0.01% | 2145 |
|
|
2015
Q2 | $29.6M | Buy |
4,322,068
+211,751
| +5% | +$1.34M | ﹤0.01% | 2180 |
|
|
2015
Q1 | $24.9M | Sell |
4,110,317
-35,037
| -0.8% | -$233K | ﹤0.01% | 2233 |
|
|
2014
Q4 | $28.7M | Buy |
4,145,354
+176,288
| +4% | +$1.3M | ﹤0.01% | 2094 |
|
|
2014
Q3 | $32.3M | Buy |
3,969,066
+223,427
| +6% | +$1.75M | ﹤0.01% | 2014 |
|
|
2014
Q2 | $30.5M | Buy |
3,745,639
+33,125
| +0.9% | +$251K | ﹤0.01% | 2067 |
|
|
2014
Q1 | $29.1M | Buy |
3,712,514
+75,085
| +2% | +$635K | ﹤0.01% | 2058 |
|
|
2013
Q4 | $32.2M | Buy |
3,637,429
+319,849
| +10% | +$2.86M | ﹤0.01% | 1987 |
|
|
2013
Q3 | $27.8M | Sell |
3,317,580
-1,182
| -0% | -$9.57K | ﹤0.01% | 1997 |
|
|
2013
Q2 | $24.8M | Buy |
+3,318,762
| New | +$25.5M | ﹤0.01% | 1996 |
|
Vanguard Group's SPPI Position: Q3 2023 in Review
Vanguard Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 8,580,357 shares — an estimated $8.24M sold.
Vanguard Group first reported a position in SPPI in Q2 2013 and held it in 41 quarters. The position peaked at $215M in Q2 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Vanguard Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Vanguard Group sold 8,580,357 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $8.24M.
- Vanguard Group first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 41 quarters.
- Vanguard Group's Spectrum Pharmaceuticals Inc position peaked at $215M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Vanguard Group's 13F filing for Q3 2023, filed 14 Nov 2023.